Neutral sphingomyelinase: Past, present and future

Chemistry and Physics of Lipids

Volumn 102, Issue 1-2, 1999, Pages 79-96

  Chatterjee, Subroto ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Apoptosis; Atherosclerosis; Cell proliferation; Signal transduction; Sterol homeostasis

Indexed keywords

CERAMIDE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; FORECASTING; HUMANS; SPHINGOMYELIN PHOSPHODIESTERASE;

ANIMALIA;

EID: 0032868933     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(99)00077-8     Document Type: Article

References (87)

1. Adam D., Wiegmann K., Adam-Klages S., Ruff A., Kronke M. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J. Biol. Chem. 271:1994;14617-14622.
2. Adam D., Wiegmann K., Adam-Klages S., Ruff A., Kronke M. Functional dichotomy of neutral and acid sphingomyelinase in tumor necrosis factor signaling. J. Biol. Chem. 271:1996;14617-14622.
3. Adam D., Wiegmann K., Struve S., Kolannus W., Schneider S., Merzener J., Kronke M. FAN is novel WDP protein, couples the p55 TNF-α-r to N-SMase. Cell. 86:1996;937-947.
4. Alessenko A., Chatterjee S. Neutral sphingomyelinase: localization in rat liver nuclei and involvement in regeneration/proliferation. Mol. Cell Biochem. 143:1995;169-174.
5. Andrieu N., Salvare R., Levade T. Comparative study of the metabolic pools of sphingomyelin and phosphatidylcholine sensitive to tumor necrosis factor. Eur. J. Biochem. 236:1996;738-745.
6. Barenholz Y., Gatt S. Sphingomyelin metabolism, chemical synthesis, chemical and physical properties. Hawthorne J.N., Ansel G.D. Phospholipids. 1982;129-177 Elsevier, Amsterdam.
7. Basu S.D., Brown M.S., Ho Y.K., Goldstein J.L. Degradation of low density lipoprotein: dextran sulfate complexes associated with dposition of cholesteryl esters in mouse macrophages. J. Biol. Chem. 254:1979;7141-7146.
8. Boldin M.P., Mett I.L., Varfolomeev E.E., Chumakov I., Shemer-Avri Y., Camouis J.H., Wallech D. Association of the 'death domain' of the p55 tumor necrosis factor-α (TNF-α) receptor and Fas (Apo) prompts signaling for TNF-α and Fas/Apo A-1 effects. J. Biol. Chem. 270:1995;387-391.
9. Bretscher M.S. Membrane structure: some general principles. Science. 181:1973;622-662.
10. Chapman M.J. Comparative analysis of mammalian plasma lipoproteins. Segrest J., Albers J. Methods in Enzymology. 128:1980;70-140 Academic Press, New York.
11. Chatterjee S. Role of oxidized low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation. Mol. Cell. Biochem. 111:1992;143-147.
12. Chatterjee S. Neutral sphingomyelinase. Adv. Lipid Res. 26:1993;25-48.
13. Chatterjee S. Neutral sphingomyelinase stimulates human plasma low density lipoprotein receptor activity in human fibroblasts. J. Biol. Chem. 268:1993;3401-3406.
14. Chatterjee S. Neutral sphingomyelinase action induces signal transduction of tumour necrosis factor-a in increasing cholesteryl ester synthesis in human fibroblasts. J. Biol. Chem. 269:1994;879-882.
15. Chatterjee S., Ghosh N. Neutral sphingomeylinase from human urine: purification and preparation of monospecific antibodies. J. Biol. Chem. 264:1989;12534-12561.
16. Chatterjee S., Ghosh N. Neutral sphingomyelinase. Methods Enzymol. 26:1993;25-48.
17. Chatterjee, S., Han, H., Rollins, S., Cleveland, T., 1999a. Molecular cloning and expression of a novel human neutral sphingomyelinase: its potential role in apoptosis. J. Biol. Chem. (submitted).
18. Chatterjee, S., Gakenheimer, K., Han, H., Dey, S., Hutchins, G., Dobromilskaya, I., Snowden, A., 1999b. Oxidized low density lipoprotein stimulates apoptosis via activation of neutral sphingomyelinase in human aortic smooth muscle cells. J. Biol. Chem. (submitted).
19. Chisolm G.M., Ma G., Irwin K.C., Martin L.L., Gunderson K.G., Linberg L.F., Morel D.W., DiCorleto P.E. 7β-Hydroperoxycholest-5-en-3β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 91:1994;11452-11456.
20. Cifone M.G., De Maria R., Oncaioli P.R., Rippor M.R., Azuma M., Lanier L.L., Santoni A., Testi R. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. J. Exp. Med. 180:1994;1547-1552.
21. Cohen G.M., Sun X.-M., Snowden R.T., Dinsdale D., Skilleter D.N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286:1992;331-334.
22. Colles S.M., Irwin K.C., Chisolm G.M. Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7β-hydroperoxycholesterol. J. Lipid Res. 37:1996;2018-2028.
23. Darnay B.G., Aggarwal B.B. Early events in TNF-α signaling: a story of associations and dissociations. J. Leuk. Biol. 61:1997;559-566.
24. Das D.V.M., Cook M.W., Spence M.W. Evidence that neutral sphingomyelinase of cultured murine neuroblastoma cells is oriented externally on the plasma membrane. Biochim. Biophys. Acta. 777:1984;339-342.
25. Dawson P.A., Hofmann S.L., van der Westhhuyzen D.R., Sudhof T.C., Brown M.S., Goldstein J.L. Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transaction factor sp1. J. Biol. Chem. 263:1988;3372-3379.
26. Feinstein E., Kimchi A., Wallach D., Boldin M., Varfolomeev E. The death domain: a model having diverse cellular functions. TIBS. 23:1995;342-344.
27. Frederickson D.S., Sloan H. Sphinomyelin lipidoses: Niemann-Pick disease. Stanbury R.B., Wyngaarden J.B., Frederickson D.F. The Metabolic Basis of Inherited Disease. 3rd edn:1972;783-807 McGraw Hill, New York.
28. Galis Z.S., Muszynski M., Sukhova G.K., Simon-Morrissey E., Libby P. Enhanced expression of vascular matrix metalloproteinaes induced by in vitro cytokines and in regions of human atherosclerotic lesions. Ann. Acad. Sci. 748:1995;501-507.
29. Gatt S. Magnesium-dependent sphingomyelinase. Biochem. Biophys. Res.Commun. 68:1976;235-241.
30. Ghosh T., Bian J., Gill D.L. Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science. 248:1990;1653-1656.
31. Ghosh, N., Sabbadini, R., Chatterjee, S., 1998. Identification, partial purification, and localization of a neutral sphingomyelinase in rabbit skeletal muscle: neutral sphingomyelinase in skeletal muscle. Mol. Cell. Biochem. 189, 161-168.
32. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 343:1986;425-430.
33. Goldstein J.L., Hopps H.H., Brown M.S. Scriver Charles L., Beaudet A.rthur A. 7th edn The Metabolic and Molecular Bases of Inherited Disease. 11:1995;1981-2030 McGraw Hill, New York.
34. Gupta A.K., Rudney H. Plasma membrane sphingomyelin and the regulation of HMG-CoA reductase activity and cholesterol biosynthesis in cell cultures. J. Lipid Res. 32:1991;125-136.
35. Haimovitz-Friedman A., Kan C.-C., Ehleiter D., Persuad R.S., McLoughlin M., Fuks Z., Kolesnick R.M. Interleukin-1 mediated PGE2 production and sphingomyelin metabolism. J. Exp. Med. 180:1994;525-535.
36. Hamanaka R., Kohno K., Seguchi T., Okamura K., Morimoto A., Ono M., Ogata J., Kuwano M. Induction of low density lipoprotein receptor and a transcription factor SP-1 by tumor necrosis factor in human microvascular endothelial cells. J. Biol. Chem. 267:1992;13160-13165.
37. Han, H., Wan, T.-C., Chatterjee, S., 1998. Antibody against N-SMase abrogates TNF-α -induced apoptosis in human leukemic (HL-60) cells. Mol. Cell. Biochem. (submitted).
38. Hannun Y.A. Ionizing radiation acts on cellular membranes to generate ceramide. J. Biol. Chem. 269:1994;3125-3138.
39. Hardwick S.J., Hegyi L., Clare K., Law N.S., Carpenter K.L.H., Mitchinson M.J., Skepper J.N. Apoptosis in human monocyte-macrophages exposed to oxidized low density lipoprotein. J. Pathol. 179:1996;294-302.
40. Higuchi M., Singh S., Jaffrezou J.P., Aggarwal B.B. Acidic sphingomyelinase generated ceramide is needed but not sufficient TNF-induced apoptosis and nuclear factor-kB activation. J. Biol. Chem. 269:1996;23530-23537.
41. Higuchi, M., Singh, S., Aggarwal, B.B., 1995. Characterisation of the apoptotic effects of human tumor records factor: development of highly rapid and specific bioassay for human tumor records factor and lymphotoxin using human target cells.
42. Hughes, B., Matthews, B., Lenz, M.L., Guyton, J.R., 1994. Cytotoxicity of Ox-LDL to porcine aortic smooth muscle cells is associated with oxysterols, 7-keto-cholesterol and 7-β-hydroxycholesterol. Art. Thrombosis, 14, 1179-1185.
43. Jaffrezou J.A., Levade T., Bettaiels A., Andrieu N., Psezmkes C., Meastre H., Vermeeroch S., Rouse A., Laurent G. Daunorubicin induced apoptosis: triggering of ceramide generation through sphinomyelin hydrolysis. EMBO J. 15:1996;2417-2424.
44. Jarvis W.D., Kolesnick R.N., Fornari F.A., Traylor R.S., Gewirtz D.A., Grant S. Sphingomyelin turnover induced by vitamin B3 in HL-60 cells. Proc. Natl. Acad. Sci. USA. 91:1994;73-77.
45. Jayadev S., Linardic C.M., Hannun Y.A. Identification of sphingomyelin tunrover as an effector mechanism for the action of tumor necrosis factor-α and V-interferon. J. Biol. Chem. 269:1994;5757-5763.
46. Jeong T.-S., Schissel S.L., Tabas I., Pownall H.J., Tall A.R., Jiang X.-C. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J. Clin. Invest. 101(4):1998;905-912.
47. Kim M.Y., Linardic C., Obeid L., Hannun Y.A. Induction of apoptosis DNA damage and cell death by activator of the sphingomyelin pathway. J. Biol. Chem. 266:1991;484-489.
48. Kinscherf R., Claus R., Deigner H.P., Nauen O., Gehrke C., Hermetter A., Rußwurm Daniel V., Hack V., Metz J. Modified low density lipoprotein delivers substrate for ceramide formation and stimulates the sphingomyelin-ceramide pathway in human macrophages. FEBS Lett. 405:1997;55-59.
49. Kolesnick R., Golde D.W. The sphingomyelin cycle and the second mesenger function of ceramide. Cell. 77:1994;325-328.
50. Lawler J., Ying M. Jr, Diehl A.M., Roberts E., Chatterjee S. Tumor necrosis factor-α stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J. Biol. Chem. 272:1998;5053-5059.
51. Lazebrik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347.
52. Linardic C.M., Hannun Y.A. Identification of a distinct pool of sphingomyelin involved in the sphingomyelin cycle. J. Biol. Chem. 269:1994;23530-23537.
53. Liu B., Obeid L.M., Hannun Y.A. Sphingomyelinases in cell regulation. Cell Dev. Biol. 8:1997;311-322.
54. Mizushima N., Koike R., Kohsaka H., Kushi Y., Handa S., Yagita H., Miyasaka N. Ceramide induces apoptosis via cpp32 activation. FEBS Lett. 395:1996;267-271.
55. Morton R.E., West G.A., Hoffl H.F.L. A low density lipoprotein particle isolated from human atherosclerotic lesions is internalized by macrophages via non-scavenger-receptor mechanism. J. Lipid Res. 27:1986;1124-1134.
56. Nicholson D.W. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat. Biotech. 14:1996;297-301.
57. Nicholson, D.W., Thornberry, N.A., 1997. Caspases: killer proteases. TIBS 2, 299-306.
58. Nishio A., Arimure S., Watanabe Y. Oxidised-LDL induces apoptosis in cultured smooth muscle cells: a possible role for 7-keto-cholesterol. Biochem. Biophys. Res. Commun. 223:1996;413-418.
59. Nishio E., Arimua S., Watanabe Y. Oxidized LDL induces apoptosis in cultured smooth muscle cells: a possible role for 7-ketocholesterol. Biochem. Biophys. Res. Commun. 223:1996;413-418.
60. Obeid L.M., Linardic C.M., Karolak L.A., Hannun Y.A. Programmed cell death induced by ceramide. Science. 259:1993;1769-1771.
61. Okazaki T., Bell R.M., Hannun Y.A. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J. Biol. Chem. 264:1989;19076-19080.
62. Okazaki T., Bielawska A., Bell R.M., Hannun Y.A. Role of ceramide as a lipid mediator of 1 α, 25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem. 265:1990;15823-15831.
63. Okazaki T., Bielawska A., Domae N., Bell R.M., Hannun Y.A. Characteristics and partial purification of a novel cytosolic magnesium independent neutral sphingomyelinase activated in the early signal transduction of α, 25-dihydroxy vitamin B3 induced HL-60 cell differentiation. J. Biol. Chem. 269:1994;4070-4077.
64. Pena L.A., Fuks Z., Kolesnick R. Stress-induces apoptosis and the sphingomyelin pathway. Biochem. Pharm. 53:1997;615-621.
65. Rangaswamy S., Penn M.S., Saidel G.M., Chisolm G.M. Exogenous oxidized low density lipoprotein injures and alters the barrier function of endothelium in rats in vivo. Circ. Res. 80:1997;37-44.
66. Rao B.G., Spence M.W. Sphingomyelinase activity of pH 7.0 in human brain and a comparison to activity at pH 5.0. J. Lipid Res. 17:1976;506-515.
67. Reed J.C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1994;1-6.
68. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
69. Santana P., Pena L.A., Haimovitz-Friedman A., Martin S., Green D., McLoughlin M., Cordon-Cardo C., Schuchmann E.H., Fuks Z., Kolesnick R. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. Cell. 86:1996;189-199.
70. Schissel S.L., Jiang X.-C., Tweedie-Hardman J., Jeong T.-S., Camejo H.H., Najib J., Rapp J.H., Williams K.J., Tabas I. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. J. Biol. Chem. 273:1998;2738-2746.
71. Schlegel R.A., Callahan M., Krahling S., Pradhan D., Williamson P. Mechanisms for recognition and phagocytosis of apoptotic lymphocytes by macrophages [Review]. Adv. Exp. Med. Biol. 406:1996;21-28.
72. Simon C.G., Chatterjee S., Gear A.R.L. Sphingomyelinase activity in human platelets. Thromb. Res. 90:1998;155-161.
73. Slotte J.P., Bierman E.L. Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem. J. 250:1988;653-658.
74. Spence M. Sphingomyelinases. Adv. Lipid Res. 26:1993;1-25.
75. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. Minireview. J. Biol. Chem. 272:1997;20963-20966.
76. Tamiya-Koizumi K., Umekawa H., Yoshida S., Kojima K. Existence of Mg2+-dependent, neutral sphingomyelinase in nuclei of rat ascites hepatoma cells. J. Biochem. (Tokyo). 106:1989;593-598.
77. Tang X., Halleck M.S., Schlegel R.A., Williamson P. A subfamily of P-type ATPases with aminophospholipid transporting activity [published erratum appears in Science 1996 Dec 6; 274 (5293):1597]. Science. 272:1996;1495-1497.
78. Tatusov R.L., Koonin E.V., Lipman D. A genomic perspective on protein families. Science. 278:1997;631-637.
79. Tomiuk S., Hofmann K., Nix M., Zumbansen M., Stoffel W. Clined mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc. Natl. Acad. Sci. USA. 95:1998;3638-3643.
80. Verheij M., Bose R., Lin X.H., Yao B., Jarvi W.D., Grant S., Birrer M.H., Szao E., Zon L.I., Kyriakis J.M., Haimovitz-Friedman A., Fuks Z., Kolesnick R.N. Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature. 380:1996;75-79.
81. Vermes, Haanen, C., Steffens-Nakken, C.H., Reutelingsperger, C., 1995. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin-V. J. Immunol. Methods 184, 39-51.
82. Wang X., Sato R., Brown M.S., Goldstein J.L. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 77:1994;53-62.
83. Wang H.-G., Rapp U.R., Reed J.C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell. 87:1996;629-638.
84. Wang X., Zelenski N.G., Yang J., Seakai J., Brown M.S., Goldstein J.L. Cleavage of sterol regulatory element binding proteins (SREBPs) by cpp32 during apoptosis. EMBO J. 15:1996;1012-1020.
85. White E. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1996;1-15.
86. Wiegmann K., Schutze S., Machleidt T., Witte D., Kronke M. Apoptotic signaling through CD95 (Fas-apo-1) activates an acidic sphingomyelinase. Cell. 78:1994;1005-1015.
87. Zhang P., Liu B., Jenkins G.M., Hannun Y.A., Obeid L.M. Extension of neutral sphingomyelinase identifies distinct roles of sphingomyelin involved in apoptosis. J. Biol. Chem. 272:1997;9609-9612.